ACHV
Achieve Life Sciences Inc
7.20$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -43.0% | +0.0% | +0.0% | +0.0% | – | – | -11.3% | -1.8% | +5.6% | +0.0% | – | – | |
| – | – | – | – | – | – | -154.4% | – | – | – | – | – | – | |
| – | -41.0% | +32.4% | +82.7% | +48.8% | -4.1% | -2.7% | -5.5% | -20.7% | -27.2% | -15.0% | +15.7% | – | |
| – | -24.0% | +40.1% | +4.2% | +46.4% | +0.8% | +18.5% | +1.0% | +60.0% | +15.8% | -34.5% | +105.0% | – | |
| – | -32.2% | +36.4% | +40.9% | +47.9% | -2.2% | +5.8% | -2.6% | +16.5% | +0.6% | -29.4% | +76.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.8% | +3.3% | -1.1% | -54.5% | -46.2% | -6.1% | +3.2% | +0.5% | +30.7% | +9.2% | +1.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.1% | +4.1% | -733.9% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.